Development of fusion fuel cycles: Large deviations from US defense program systems

Klein, James Edward; Poore, Anita Sue; Babineau, David W.

doi:10.1016/j.fusengdes.2015.02.031

Title: Development of fusion fuel cycles: Large deviations from US defense program systems

Full Record
Other Related Research

Authors:: Klein, James Edward; Poore, Anita Sue; Babineau, David W.

Publication Date:: Thu Oct 01 00:00:00 EDT 2015

Sponsoring Org.:: USDOE

OSTI Identifier:: 1250132

Resource Type:: Publisher's Accepted Manuscript

Journal Name:: Fusion Engineering and Design

Additional Journal Information:: Journal Name: Fusion Engineering and Design Journal Volume: 96-97 Journal Issue: C; Journal ID: ISSN 0920-3796

Publisher:: Elsevier

Country of Publication:: Netherlands

Language:: English

Citation Formats


                    Klein, James Edward, Poore, Anita Sue, and Babineau, David W. Development of fusion fuel cycles: Large deviations from US defense program systems.  Netherlands: N. p., 2015. 
Web.  doi:10.1016/j.fusengdes.2015.02.031.

Copy to clipboard


                    Klein, James Edward, Poore, Anita Sue, & Babineau, David W. Development of fusion fuel cycles: Large deviations from US defense program systems.  Netherlands.  https://doi.org/10.1016/j.fusengdes.2015.02.031

Copy to clipboard


                    Klein, James Edward, Poore, Anita Sue, and Babineau, David W. Thu .  
"Development of fusion fuel cycles: Large deviations from US defense program systems".  Netherlands.  https://doi.org/10.1016/j.fusengdes.2015.02.031.

Copy to clipboard


                    
@article{osti_1250132,

  title        = {Development of fusion fuel cycles: Large deviations from US defense program systems},

  author       = {Klein, James Edward and Poore, Anita Sue and Babineau, David W.},

  abstractNote = {},

  doi          = {10.1016/j.fusengdes.2015.02.031},

  journal      = {Fusion Engineering and Design},

  number       = C,

  volume       = 96-97,

  place        = {Netherlands},

  year         = {Thu Oct 01 00:00:00 EDT 2015},

  month        = {Thu Oct 01 00:00:00 EDT 2015}

}

Copy to clipboard

Journal Article:

Free Publicly Available Full Text

Accepted Manuscript (Publisher)

Publisher's Version of Record
https://doi.org/10.1016/j.fusengdes.2015.02.031

Other availability

Search WorldCat to find libraries that may hold this journal

Citation Metrics:

Cited by: 1 work

Citation information provided by
Web of Science

Save / Share:

Export Metadata

Save to My Library

Similar Records in DOE PAGES and OSTI.GOV collections:

DEVELOPMENT OF FUSION FUEL CYCLES: LARGE DEVIATIONS FROM US DEFENSE PROGRAM SYSTEMS

Conference Klein, J. ; Poore, A. ; Babineau, D.
Full Text Available
Multiple animal studies for medical chemical defense program in soldier/patient decontamination and drug development on task order 85-13: Advanced screening system for evaluating barrier compounds for protection from organophosphate chemical surety material using a nonlethal end point, acetylcholinesterase inhibition. Final report, 1 January 1985-1 September 1988

Technical Report Joiner, R L ; Dill, S ; Olson, T ; ...

This task was initiated at the Medical Research and Evaluation Facility to develop a protocol for advanced screening of candidate barrier compounds for protection from nerve agents using a quantifiable nonlethal end point as a measure of effectiveness. Soman (GD), thickened GD (TGD), and VX were used to generate a family of curves for erythrocyte (RBC) acetylcholinesterase (AChE) inhibition as a function these data, a single dose was selected for each agent to challenge barrier-protected and unprotected animals. Blood samples were drawn at three times after exposure from each group of agent-challenged animals to validate the model by comparing AChEmore »« less
Multiple animal studies for medical chemical defense program in soldier/patient decontamination and drug development. Task 85-18. Appendix A. Protocol, amendments and deviations. Final report, June 1985-August 1988

Technical Report Joiner, R L ; Kluwe, M

This study was conducted to evaluate the efficacy of the reversible acetylcholinesterase inhibitor, pyridostigmine bromide, as a addition to standard therapy with atropine and pralidoxime chloride (2-PAM), against the acute lethal effects of Soman, GD, using a primate model (male, Rhesus monkey). In addition, the pharmacokinetics of pyridostigmine bromide (intragastric), atropine (intramuscular), and 2-PAM (intramuscular) were individually examined in the primate model using three different dose levels for each compound. In the efficacy study, the combined prophylactic/post-challenge therapy regimen resulted in survival following an intramuscular challenge dose as high as 617 micro g/kg in contrast to an estimated, unprotected, medianmore »« less
Comparison of two thorium fuel cycles for use in light water prebreeder/breeder reactor systems (AWBA Development Program)

Technical Report Merriman, F C ; McCoy, D F ; Boyd, W A ; ...

Light water prebreeder/breeder conceptual reactor systems have been developed which have the potential to significantly improve the fuel utilization of present generation light water reactors. The purpose of this study is to describe and compare two possible types of thorium fuel cycles for use in these light water prebreeder and breeder concepts. The two types of thorium fuel cycles basically differ in the fuel rod design used in the prebreeder cores and the uranium isotopic concentration of fuel supplied to the breeder cores.
LARGE CLOSED-CYCLE WATER REACTOR RESEARCH AND DEVELOPMENT PROGRAM. DEVELOPMENT OF AUXILIARY SYSTEMS

Technical Report Cordle, H J

Similar Records